Myc is overexpressed in several types of cancer, which is why studies have been carried out in lung cancer, using CRISPR technology to suppress the expression of this gene by creating Myc knock-out cells, thereby reducing tumor malignancy [38]. The gene discussed is MYC; the disease is lung carcinoma.